Dividend investing is not just about finding the biggest yield; it is about finding payouts that can be maintained and grown over time. A practical way to do this is to screen for stocks with a high ChartMill Dividend Rating while requiring minimum levels of profitability and financial health. STRYKER CORP (NYSE:SYK) is one of the names that appears when running such a screen.
A dividend profile built on sustainability
Stryker’s ChartMill Dividend Rating of 7 out of 10 is the key reason it qualifies for this strategy. The company offers a yearly dividend yield of 1.01%, which is well above the 0.25% average for its Health Care Equipment & Supplies industry peers. While that yield is lower than the broader S&P 500 average of 1.73%, the more important factors for dividend investors are the track record and the payout ratio.
The fundamental report shows that Stryker has paid a dividend for at least 10 years and has not decreased it during that period. The dividend has also grown at an average annual rate of 7.89%, which points to a consistent commitment to returning cash to shareholders. Crucially, the payout ratio stands at 38.99% of earnings; that is a moderate and sustainable level, leaving plenty of room for the company to reinvest in its business or increase the payout.
Investors who want to see the full detail behind these ratings can review the fundamental analysis report for Stryker.
Profitability supports the dividend
A dividend is only as reliable as the earnings behind it, and Stryker scores well here. The company holds a ChartMill Profitability Rating of 9 out of 10, with several metrics ranking near the top of its industry.
- Return on Invested Capital: 11.12%, outperforming 93.12% of industry peers
- Return on Equity: 14.52%, outperforming 88.89% of peers
- Operating Margin: 22.31%, outperforming 95.24% of peers
- Profit Margin: 13.21%, outperforming 88.36% of peers
The fundamental report also notes that Stryker was profitable in each of the past five years and generated positive operating cash flow over the same period. For dividend investors, this profitability matters because it gives the company the financial capacity to maintain and grow its dividend through different market conditions.
Health rating clears the screen’s bar
The Best Dividend screen requires a minimum ChartMill Health Rating of 5, and Stryker sits exactly at that level. This is the weakest part of its fundamental profile, so it deserves attention.
On the positive side, Stryker has an Altman-Z score of 4.98, indicating a low risk of bankruptcy, and a debt-to-free-cash-flow ratio of 3.22, which is better than 82.54% of its peers. Its current ratio of 2.11 also suggests no immediate liquidity problems.
However, the health rating is held back by a debt-to-equity ratio of 0.62, which is higher than about two-thirds of the industry, and by an increase in shares outstanding compared with one and five years ago. These factors do not disqualify Stryker as a dividend candidate, but they are worth monitoring, especially for investors with a long holding period.
Key dividend metrics at a glance
- Dividend Rating: 7 / 10
- Dividend Yield: 1.01% vs. industry average of 0.25%
- 5-Year Average Dividend Growth: 7.89%
- Payout Ratio: 38.99% of earnings
- Profitability Rating: 9 / 10
- Health Rating: 5 / 10
Why this approach matters for income investors
The strategy behind the Best Dividend screen is to avoid the common trap of chasing a high yield that turns out to be unsustainable. A stock can look attractive on yield alone, but if the payout is not supported by earnings and a reasonably healthy balance sheet, the dividend may be cut. Stryker fits the screen because it offers a moderate but well-covered yield, a long track record of dividend growth, and strong profitability. Its health rating is not outstanding, but it still meets the minimum threshold that keeps the focus on financially viable companies.
Investors who want to see which other stocks currently match this methodology can run the Best Dividend Stocks screen and adjust the filters to their own preferences.
Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Always conduct your own research and consider your risk tolerance before making investment decisions.
Read full article here »
View the Zacks #1 Rank List
Stryker (NYSE:SYK): A Dividend Quality Play Built on Sustainability
Dividend investing is not just about finding the biggest yield; it is about finding payouts that can be maintained and grown over time. A practical way to do this is to screen for stocks with a high ChartMill Dividend Rating while requiring minimum levels of profitability and financial health. STRYKER CORP (NYSE:SYK) is one of the names that appears when running such a screen.
A dividend profile built on sustainability
Stryker’s ChartMill Dividend Rating of 7 out of 10 is the key reason it qualifies for this strategy. The company offers a yearly dividend yield of 1.01%, which is well above the 0.25% average for its Health Care Equipment & Supplies industry peers. While that yield is lower than the broader S&P 500 average of 1.73%, the more important factors for dividend investors are the track record and the payout ratio.
The fundamental report shows that Stryker has paid a dividend for at least 10 years and has not decreased it during that period. The dividend has also grown at an average annual rate of 7.89%, which points to a consistent commitment to returning cash to shareholders. Crucially, the payout ratio stands at 38.99% of earnings; that is a moderate and sustainable level, leaving plenty of room for the company to reinvest in its business or increase the payout.
Investors who want to see the full detail behind these ratings can review the fundamental analysis report for Stryker.
Profitability supports the dividend
A dividend is only as reliable as the earnings behind it, and Stryker scores well here. The company holds a ChartMill Profitability Rating of 9 out of 10, with several metrics ranking near the top of its industry.
The fundamental report also notes that Stryker was profitable in each of the past five years and generated positive operating cash flow over the same period. For dividend investors, this profitability matters because it gives the company the financial capacity to maintain and grow its dividend through different market conditions.
Health rating clears the screen’s bar
The Best Dividend screen requires a minimum ChartMill Health Rating of 5, and Stryker sits exactly at that level. This is the weakest part of its fundamental profile, so it deserves attention.
On the positive side, Stryker has an Altman-Z score of 4.98, indicating a low risk of bankruptcy, and a debt-to-free-cash-flow ratio of 3.22, which is better than 82.54% of its peers. Its current ratio of 2.11 also suggests no immediate liquidity problems.
However, the health rating is held back by a debt-to-equity ratio of 0.62, which is higher than about two-thirds of the industry, and by an increase in shares outstanding compared with one and five years ago. These factors do not disqualify Stryker as a dividend candidate, but they are worth monitoring, especially for investors with a long holding period.
Key dividend metrics at a glance
Why this approach matters for income investors
The strategy behind the Best Dividend screen is to avoid the common trap of chasing a high yield that turns out to be unsustainable. A stock can look attractive on yield alone, but if the payout is not supported by earnings and a reasonably healthy balance sheet, the dividend may be cut. Stryker fits the screen because it offers a moderate but well-covered yield, a long track record of dividend growth, and strong profitability. Its health rating is not outstanding, but it still meets the minimum threshold that keeps the focus on financially viable companies.
Investors who want to see which other stocks currently match this methodology can run the Best Dividend Stocks screen and adjust the filters to their own preferences.
Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Always conduct your own research and consider your risk tolerance before making investment decisions.
Read full article here »